scholarly journals Introduction: Genetic Hepatobiliary Disease

2021 ◽  
Author(s):  
Alanna Strong
1980 ◽  
Vol 15 (4) ◽  
pp. 509-512 ◽  
Author(s):  
Ryoji Ohi ◽  
John R. Lilly

1998 ◽  
Vol 18 (03) ◽  
pp. 195-202 ◽  
Author(s):  
Mounif El-Youssef ◽  
Peter Whitington

1996 ◽  
Vol 12 (5) ◽  
pp. 477-481
Author(s):  
David A. Wiechmann ◽  
James E. Heubi

1994 ◽  
Vol 14 (03) ◽  
pp. 259-269 ◽  
Author(s):  
Carla Colombo ◽  
Pier Battezzati ◽  
Mauro Podda

2021 ◽  
Vol 8 (1) ◽  
pp. 01-06
Author(s):  
Marilena Stoian

We present a case of a 38-year -old man was admitted to the hospital with biliary obstruction and Clostridium Difficile infection. He presented with moderate increases in the aminotransferase and bilirubin levels suggesting the diagnosis of an autoimmune hepatobiliary disease; intestinal protein loss needs to evaluate an associated inflammatory bowel disease. The clinical diagnosis of autoimmune hepatobiliary disease associated with inflammatory bowel disease is based on the patients symptoms and the presence of a protein-losing enteropathy which are more suggestive of Crohn disease, while moderate increases in the aminotransferase levels in proportion to the increase in the bilirubin level suggesting the diagnosis of primary sclerosing cholangitis. The pathological and positive diagnosis needs an endoscopic retrograde cholangiopancreatography and a biopsy of gastric and duodenum mucosae who showed severe inflammation findings that are diagnostic of Crohn disease.


BMJ ◽  
1999 ◽  
Vol 319 (7208) ◽  
pp. 471-477 ◽  
Author(s):  
I. Mushtaq ◽  
S. Logan ◽  
M. Morris ◽  
A. W Johnson ◽  
A. M Wade ◽  
...  

1954 ◽  
Vol 16 (6) ◽  
pp. 905 ◽  
Author(s):  
Emanuel E. Mandel ◽  
Thomas L. Gorsuch ◽  
Florence L. Jones

Sign in / Sign up

Export Citation Format

Share Document